搜索临床试验以:Camrelizumab (SHR-1210)
总计3181个结果
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.完全的局部晚期或转移性和不可切除的 HCC美国, 西班牙, 中国, 台湾, 比利时, 大韩民国, 意大利, 香港, 俄罗斯联邦, 乌克兰, 火鸡, 波兰, 德国
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
The First Affiliated Hospital of Zhengzhou University尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
SYZ Cell Therapy Co..Peking University Cancer Hospital & Institute未知
-
Sixth Affiliated Hospital, Sun Yat-sen University尚未招聘
-
Peking Union Medical College Hospital招聘中
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University完全的
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Chinese PLA General Hospital招聘中
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Huazhong University of Science and Technology尚未招聘
-
Zhou FuxiangHubei Cancer Hospital; Henan Provincial People's Hospital; Huangshi Central Hospital, China招聘中
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Heike E Daldrup-Link完全的